Androstane metabolites bind to and deactivate the nuclear receptor CAR- β

Nature

Volumn 395, Issue 6702, 1998, Pages 612-615

  Forman, Barry M ^a,b   Tzameli, Iphigenia ^c   Choi, Hueng Sik ^d   Chen, Jasmine ^a,b   Simha, Devendranath ^e   Seol, Wongi ^f   Evans, Ronald M ^b   Moore, David D ^c  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d Chonnam National University   (South Korea)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

^f DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5ALPHA ANDROSTANE DERIVATIVE; ANDROSTANE DERIVATIVE; ANDROSTERONE; CELL NUCLEUS RECEPTOR; CONSTITUTIVE ANDROSTANE RECEPTOR BETA; UNCLASSIFIED DRUG;

ANDROGEN METABOLISM; ANIMAL CELL; ARTICLE; ENZYME ACTIVITY; LIGAND BINDING; MONKEY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN DOMAIN;

ANDROSTANES; ANDROSTANOLS; ANIMALS; BINDING SITES; COS CELLS; LIGANDS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECOMBINANT FUSION PROTEINS; SACCHAROMYCES CEREVISIAE; STEREOISOMERISM; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TRANSFECTION;

ANIMALIA;

EID: 0032497544     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/26996     Document Type: Article

References (26)

1. Choi, H. S. et al. Differential transactivation by two isoforrns of the orphan nuclear hormone receptor CAR. J. Biol. Chem. 272, 23565-23571 (1997).
2. 2-adrenoceptor. Nature 374, 272-276 (1995).
3. Klein, E. S. et al. Identification and functional separation of retinoic acid receptor neutral antagonists and inverse agonists. J. Biol. Chem. 271, 22692-22696 (1996).
4. Singer, A. G. A chemistry of mammalian pheromones. J. Steroid Biochem. Mol. Biol. 39, 627-632 (1991).
5. Weusten, J. J. et al. The mechanism of the synthesis of 16-androstenes in human testicular homogenates. J. Steroid Biochem. 32, 689-694 (1989).
6. Forman, B. M. et al. The orphan nuclear receptor LXRalpha is positively and negatively regulated by distinct products of mevalonate metabolism. Proc. Natl Acad. Sci. USA 94, 10588-10593 (1997).
7. Onate, S. A., Tsai, S. Y., Tsai, M. J. & O'Malley, B. W. Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science 270, 1354-1357 (1995).
8. Krey, G. et al. Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay. Mol. Endocrinol. 11, 779-791 (1997).
9. Kliewer, S. A. et al. An orphan nuclear receptor activated by pregnanes defines a novel steroid signaling pathway. Cell 92, 73-82 (1998).
10. Wagner, R. L., Apriletti, J. W., McGrath, M. E., West, B. L., Baxter, J. D. A structural role for hormone in the thyroid hormone receptor. Nature 378, 690-697 (1995).
11. Renaud, J. P. et al. Crystal structure of the RAR-gamma ligand-binding domain bound to all-trans retinoic acid. Nature 378, 681-689 (1995).
12. Bickneli, D. C. & Gower, D. B. The development and application of a radioimmunoassay for 5alpha-androst-16-en-3alpha-ol in plasma. J. Steroid Biochem. 7, 451-455 (1976).
13. Gower, D. B. et al. Comparison of 16-androstene steroid concentrations in sterile apocrine sweat and axillary secretions: interconversions of 16-androstenes by the axillary microflora - a mechanism for axillary odour production in man? J. Steroid Biochem. Mol. Biol. 48, 409-418 (1994).
14. Louveau, I., Bonneau, M. & Gower, D. B. Biosynthesis of 16-androstene steroids and testosterone by porcine testis tissue in vitro: effect of age and relationships with fat 5 alpha-androstenone levels in vivo. Acta Endocrinol. 125, 526-531 (1991).
15. Janowski, B. A. et al. An oxysterol signalling pathway mediated by the nuclear receptor LXR alpha. Nature 383, 728-731 (1996).
16. Lehmann, J. M. et al. Activation of nuclear receptor LXR by oxysterols defines a new hormone response pathway. J. Biol. Chem. 272, 3137-3140 (1997).
17. Lala, D. S. et al. Activation of the orphan nuclear receptor steroidogenic factor 1 by oxysterols. Proc. Natl Acad. Sci. USA 94, 4895-4900 (1997).
18. Forman, B. M., Chen, J. & Evans, R. M. Hypolipidemic drugs, polyunsaturated fatty acids and eicosanoids are ligands for peroxisome proliferator-activated receptors α and δ. Proc. Natl Acad. Sci. USA 94, 4312-4317 (1997).
19. Kliewer, S. A. et al. Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors α and γ. Proc. Natl Acad. Sci. USA 94, 4318-4323 (1997).
20. Forman, B. M., Umesono, K., Chen, J. & Evans, R. M. Unique response pathways are established by allosteric interactions among nuclear hormone receptors. Cell 81, 541-550 (1995).
21. Forman, B. M. et al. Identification of a nuclear receptor that is activated by farnesol metabolites. Cell 81, 687-693 (1995).
22. Seol, W., Choi, H. S. & Moore, D. D. An orphan nuclear hormone receptor that lacks a DNA binding domain and heterodimerizes with other receptors. Science 272, 1136-1139 (1996).
23. Ladias, J. A. & Karathanasis, S. K. Regulation of the apolipoprotein A1 gene by ARP-1, a novel member of the steroid recetor superfamily. Science 251, 561-565 (1991).
24. Golemis, E. A. & Brent, R. Fused protein domains inhibit DNA binding by LexA. Mol. Cell. Biol. 12, 3006-3014 (1992).
25. Gyuris, J., Golemis, E., Chartkov, H. & Brent, R. Cdil, a human G1 and S phase protein phosphatase that associates with Cdk2, Cell 75, 791-803 (1993).
26. Lee, J. W., Moore, D. D. & Heyman, R. A. A chimeric thyroid hormone receptor constitutively bound to DNA requires retinoid X receptor for hormone-dependent transcriptional activation in yeast. Mol. Endocrinol. 8, 1245-1252 (1994).